The Role of Spontaneous Events Databases for Benefit-Risk Analysis

被引：0
|
作者：
Qizilbash, Nawab [1 ,2 ]
Mendez, Ignacio [2 ]
Sanchez de la Rosa, Rainel [3 ]
机构：
[1] Oxon Epidemiol Ltd, London, England
[2] Oxon Epidemiol Ltd, Madrid, Spain
[3] Teva Pharma SLU, Dept Med, Madrid, Spain
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
242
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] THE ROLE OF SPONTANEOUS EVENTS DATABASES FOR BENEFIT-RISK ANALYSIS
    Qizilbash, N.
    Mendez, I
    Sanchez-de la Rosa, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A318 - A319
  • [2] NSAIDs: risk of thrombotic events but positive benefit-risk balance
    [J]. Reactions Weekly, 2006, 1125 (1) : 2 - 2
  • [3] FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals
    Lackey, Leila
    Thompson, Graham
    Eggers, Sara
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 170 - 179
  • [4] A RADIATION BENEFIT-RISK ANALYSIS OF MAMMOGRAPHY
    JAYARAMAN, S
    AGARWAL, SK
    READ, M
    BHADURI, D
    [J]. MEDICAL PHYSICS, 1981, 8 (04) : 575 - 575
  • [5] Benefit-Risk Analysis important for Manipulations
    不详
    [J]. MANUELLE THERAPIE, 2019, 23 (04) : 153 - 153
  • [6] To transplant or not: Benefit-risk analysis.
    Djulbegovic, B
    Hozo, I
    Greenwich, M
    Hozo, S
    [J]. BLOOD, 2000, 96 (11) : 436A - 437A
  • [7] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [8] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [9] Benefit-risk analysis for prescribing triphenylmethane dyes
    Nuernberg, W.
    Reimann, H.
    [J]. HAUTARZT, 2008, 59 (10): : 833 - 837
  • [10] Benefit-risk analysis of hormone replacement therapy
    Leidenberger, FA
    [J]. GYNAKOLOGE, 1997, 30 (04): : 314 - 325
12345